Daniel Arumi
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Correction: Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: November 19, 2024
Safety and Effectiveness of Oral Anticoagulants in Atrial Fibrillation: Real-World Insights Using Natural Language Processing and Machine Learning.
Journal: Journal of clinical medicine
Published: August 30, 2024
Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: April 24, 2024
Use of digital health tools in inflammatory bowel disease.
Journal: Gastroenterologia y hepatologia
Published: November 29, 2023
Cost-Effectiveness Analysis of Abrocitinib Compared with Other Systemic Treatments for Severe Atopic Dermatitis in Spain.
Journal: PharmacoEconomics - open
Published: November 22, 2023
Cost-effectiveness of direct oral anticoagulants compared to low-molecular-weight-heparins for treatment of cancer associated venous thromboembolism in Spain.
Journal: Journal of medical economics
Published: June 15, 2022
Safety Profile and Tolerability of Topical Phosphodiesterase 4 Inhibitors for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis.
Journal: Current therapeutic research, clinical and experimental
Published: March 06, 2022
Characteristics and management of patients with stroke and major hemorrhagic episodes with atrial fibrillation under vitamin K antagonist therapy. EVENTHO study.
Journal: Medicina clinica
Published: July 26, 2021
Do patient characteristics predict which patients with overactive bladder benefit from a higher fesoterodine dose?
Journal: International urogynecology journal
Published: December 06, 2017
Characteristics of antimuscarinic responders versus suboptimal responders in a randomized clinical trial of patients with overactive bladder symptoms.
Journal: Current medical research and opinion
Published: August 01, 2017
Profile of oab patient on treatment with flexible-dose antimuscarinic drugs in daily clinical practice.
Journal: Archivos espanoles de urologia
Published: January 03, 2017
Last Updated: 09/26/2026